Impedimed Overview
- Founded
-
1999
- Status
-
Public
- Employees
-
73
- Stock Symbol
-
IPD
- Investments
-
2
- Share Price
-
$0.04
- (As of Thursday Closing)
Impedimed General Information
Description
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data.
Contact Information
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
ASX
Primary Office
- Unit 1
- 50 Parker Court
- Pinkenba, Queensland 4008
- Australia
+61 (07) 0000 0000
Impedimed Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.04 | $0.04 | $0.04 - $0.14 | $74.9M | 1.78B | 1.97M |
Impedimed Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 30-Jun-2021 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 |
|---|---|---|---|---|
| EV | 156,626 | 103,248 | 29,761 | 14,578 |
| Revenue | 6,227 | 3,814 | 2,930 | |
| EBITDA | (14,117) | (13,351) | (16,899) | |
| Net Income | (15,437) | (14,319) | (17,248) | |
| Total Assets | 25,699 | 22,719 | 15,814 | |
| Total Debt | 356 | 598 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Impedimed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Impedimed Patents
Impedimed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019348188-A1 | Evaluating impedance measurements | Pending | 27-Sep-2018 | 0000000000 | |
| EP-3856024-A1 | Evaluating impedance measurements | Pending | 27-Sep-2018 | 0000000000 | |
| JP-2020523162-A | Index determination | Pending | 14-Jun-2017 | 0000000000 | |
| EP-3634226-A1 | Indicator determination | Pending | 14-Jun-2017 | 0000000000 | |
| AU-2018286480-A1 | Indicator determination | Pending | 14-Jun-2017 | A61B5/0537 |
Impedimed Executive Team (5)
Impedimed Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Cherrell Hirst | Impedimed | Chairman | 000 0000 |
Impedimed Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Impedimed Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 | 26-Oct-2015 | 0000000000 | Surgical Devices | 0000000 0 | |
| XiTRON Technologies | 01-Oct-2007 | Merger/Acquisition | Electronic Equipment and Instruments | 0000000 0 |
Impedimed Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 00000000000 | 01-Oct-2007 | 000000000000000000 | Completed |
|